Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             38 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A disease-modifying approach to the treatment of IgA nephropathy targeting mucosal IgA synthesis and beyond Coppo, Rosanna

103 2 p. 258-261
artikel
2 Anomalous kinetics of galactose-deficient IgA incurring nephropathy revealed by cross-scale optical imaging Si, Meijun

103 2 p. 320-330
artikel
3 A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease Steinbrenner, Inga

103 2 p. 421-424
artikel
4 CD248 induces a maladaptive unfolded protein response in diabetic kidney disease Krishnan, Shruthi

103 2 p. 304-319
artikel
5 Complementary medicine and phospholipase A2 receptor (PLA2R)–related membranous nephropathy—fortuitous or causal? Kaur, Prabhjot

103 2 p. 425-427
artikel
6 Corrigendum to “Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors.” Kidney Int. 2022;102:661–665 Giarratano, Ylenia

103 2 p. 429-430
artikel
7 Corrigendum to “Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner.” Kidney Int. 2022;102:577–591 Wang, Wei

103 2 p. 429
artikel
8 Does kidney transplant improve health-related quality of life for youth with chronic kidney disease? Johnson, Rebecca J.

103 2 p. 256-258
artikel
9 Editorial Board
103 2 p. A1
artikel
10 Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease Mann, Johannes F.E.

103 2 p. 403-410
artikel
11 Erdheim-Chester disease: hairy kidney and coated aorta Ritter, Alexander

103 2 p. 431
artikel
12 Estimating the prevalence of chronic kidney disease while accounting for nonrandom testing with inverse probability weighting Mazhar, Faizan

103 2 p. 416-420
artikel
13 False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus Caza, Tiffany N.

103 2 p. 425
artikel
14 False positivity for PLA2R1 antibody measured by ELISA in a nephrotic patient with no membranous nephropathy Hoxha, Elion

103 2 p. 411-415
artikel
15 Glomerular diseases in pregnancy: pragmatic recommendations for clinical management Fakhouri, Fadi

103 2 p. 264-281
artikel
16 Good and evil, more reasons to study UPR Inagi, Reiko

103 2 p. 254-256
artikel
17 Hematopoietic-specific melanocortin 1 receptor signaling protects against nephrotoxic serum nephritis and mediates the beneficial effect of melanocortin therapy Guan, Xuejing

103 2 p. 331-342
artikel
18 In memoriam: Rashad Sami Barsoum Naicker, Saraladevi

103 2 p. 236-238
artikel
19 in this issue
103 2 p. 235
artikel
20 Journal Club
103 2 p. 243-245
artikel
21 Kidney injury and congenital solitary functioning kidney: more research efforts are needed Marzuillo, Pierluigi

103 2 p. 427-428
artikel
22 Longitudinal assessment of the health-related quality of life of children and adolescents with chronic kidney disease Guha, Chandana

103 2 p. 357-364
artikel
23 Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice Tomas, Nicola M.

103 2 p. 297-303
artikel
24 Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring Kikić, Željko

103 2 p. 365-377
artikel
25 Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy Barratt, Jonathan

103 2 p. 391-402
artikel
26 Subscription Information
103 2 p. A2
artikel
27 Table of Contents
103 2 p. A3, A5, A7, A8
artikel
28 Taking the A(llorecognition) train: connecting passenger T cells to DSA Perkins, Griffith B.

103 2 p. 246-248
artikel
29 Targeting inflammation to treat diabetic kidney disease: the road to 2030 Rayego-Mateos, Sandra

103 2 p. 282-296
artikel
30 The authors reply Caza, Tiffany N.

103 2 p. 427
artikel
31 The authors reply Groen in ’t Woud, Sander

103 2 p. 428
artikel
32 The Case | A benign reason behind a malignant finding Bharati, Joyita

103 2 p. 433-434
artikel
33 The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus Shim, Joo Sung

103 2 p. 343-356
artikel
34 The pathologic spectrum of adenovirus nephritis in the kidney allograft Jagannathan, Geetha

103 2 p. 378-390
artikel
35 TIPS to decide whether to prescribe aspirin for the primary prevention of cardiovascular events in chronic kidney disease Roshanov, Pavel S.

103 2 p. 261-263
artikel
36 Toward a bona fide animal model of PLA2R1-associated membranous nephropathy: one step forward Bihl, Franck

103 2 p. 251-253
artikel
37 Unique problems for the design of the first trials of transplanting porcine kidneys into humans Reese, Peter P.

103 2 p. 239-242
artikel
38 Uromodulin and CKD: insight into variant pathogenicity Franceschini, Nora

103 2 p. 248-250
artikel
                             38 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland